Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. / Flensted-Jensen, Mathias; Oró, Denise; Rørbeck, Emma A.; Zhang, Chen; Madsen, Martin Rønn; Madsen, Andreas Nygaard; Norlin, Jenny; Feigh, Michael; Larsen, Steen; Hansen, Henrik H.

In: BMC Gastroenterology, Vol. 24, No. 1, 59, 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Flensted-Jensen, M, Oró, D, Rørbeck, EA, Zhang, C, Madsen, MR, Madsen, AN, Norlin, J, Feigh, M, Larsen, S & Hansen, HH 2024, 'Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH', BMC Gastroenterology, vol. 24, no. 1, 59. https://doi.org/10.1186/s12876-024-03141-x

APA

Flensted-Jensen, M., Oró, D., Rørbeck, E. A., Zhang, C., Madsen, M. R., Madsen, A. N., Norlin, J., Feigh, M., Larsen, S., & Hansen, H. H. (2024). Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. BMC Gastroenterology, 24(1), [59]. https://doi.org/10.1186/s12876-024-03141-x

Vancouver

Flensted-Jensen M, Oró D, Rørbeck EA, Zhang C, Madsen MR, Madsen AN et al. Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. BMC Gastroenterology. 2024;24(1). 59. https://doi.org/10.1186/s12876-024-03141-x

Author

Flensted-Jensen, Mathias ; Oró, Denise ; Rørbeck, Emma A. ; Zhang, Chen ; Madsen, Martin Rønn ; Madsen, Andreas Nygaard ; Norlin, Jenny ; Feigh, Michael ; Larsen, Steen ; Hansen, Henrik H. / Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. In: BMC Gastroenterology. 2024 ; Vol. 24, No. 1.

Bibtex

@article{2879480c488c4bda9f7024c33abdec1c,
title = "Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH",
abstract = "Background: Hepatocellular senescence may be a causal factor in the development and progression of non-alcoholic steatohepatitis (NASH). The most effective currently available treatment for NASH is lifestyle intervention, including dietary modification. This study aimed to evaluate the effects of dietary intervention on hallmarks of NASH and molecular signatures of hepatocellular senescence in the Gubra-Amylin NASH (GAN) diet-induced obese (DIO) and biopsy-confirmed mouse model of NASH. Methods: GAN DIO-NASH mice with liver biopsy-confirmed NASH and fibrosis received dietary intervention by switching to chow feeding (chow reversal) for 8, 16 or 24 weeks. Untreated GAN DIO-NASH mice and chow-fed C57BL/6J mice served as controls. Pre-to-post liver biopsy histology was performed for within-subject evaluation of NAFLD Activity Score and fibrosis stage. Terminal endpoints included blood/liver biochemistry, quantitative liver histology, mitochondrial respiration and RNA sequencing. Results: Chow-reversal promoted substantial benefits on metabolic outcomes and liver histology, as demonstrated by robust weight loss, complete resolution of hepatomegaly, hypercholesterolemia, elevated transaminase levels and hepatic steatosis in addition to attenuation of inflammatory markers. Notably, all DIO-NASH mice demonstrated ≥ 2 point significant improvement in NAFLD Activity Score following dietary intervention. While not improving fibrosis stage, chow-reversal reduced quantitative fibrosis markers (PSR, collagen 1a1, α-SMA), concurrent with improved liver mitochondrial respiration, complete reversal of p21 overexpression, lowered γ-H2AX levels and widespread suppression of gene expression markers of hepatocellular senescence. Conclusions: Dietary intervention (chow reversal) substantially improves metabolic, biochemical and histological hallmarks of NASH and fibrosis in GAN DIO-NASH mice. These benefits were reflected by progressive clearance of senescent hepatocellular cells, making the model suitable for profiling potential senotherapeutics in preclinical drug discovery for NASH.",
keywords = "Animal model, Dietary intervention, Fibrosis, Hepatocellular senescence, Mitochondrial respiration, Non-alcoholic steatohepatitis",
author = "Mathias Flensted-Jensen and Denise Or{\'o} and R{\o}rbeck, {Emma A.} and Chen Zhang and Madsen, {Martin R{\o}nn} and Madsen, {Andreas Nygaard} and Jenny Norlin and Michael Feigh and Steen Larsen and Hansen, {Henrik H.}",
year = "2024",
doi = "10.1186/s12876-024-03141-x",
language = "English",
volume = "24",
journal = "B M C Gastroenterology",
issn = "1471-230X",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

AU - Flensted-Jensen, Mathias

AU - Oró, Denise

AU - Rørbeck, Emma A.

AU - Zhang, Chen

AU - Madsen, Martin Rønn

AU - Madsen, Andreas Nygaard

AU - Norlin, Jenny

AU - Feigh, Michael

AU - Larsen, Steen

AU - Hansen, Henrik H.

PY - 2024

Y1 - 2024

N2 - Background: Hepatocellular senescence may be a causal factor in the development and progression of non-alcoholic steatohepatitis (NASH). The most effective currently available treatment for NASH is lifestyle intervention, including dietary modification. This study aimed to evaluate the effects of dietary intervention on hallmarks of NASH and molecular signatures of hepatocellular senescence in the Gubra-Amylin NASH (GAN) diet-induced obese (DIO) and biopsy-confirmed mouse model of NASH. Methods: GAN DIO-NASH mice with liver biopsy-confirmed NASH and fibrosis received dietary intervention by switching to chow feeding (chow reversal) for 8, 16 or 24 weeks. Untreated GAN DIO-NASH mice and chow-fed C57BL/6J mice served as controls. Pre-to-post liver biopsy histology was performed for within-subject evaluation of NAFLD Activity Score and fibrosis stage. Terminal endpoints included blood/liver biochemistry, quantitative liver histology, mitochondrial respiration and RNA sequencing. Results: Chow-reversal promoted substantial benefits on metabolic outcomes and liver histology, as demonstrated by robust weight loss, complete resolution of hepatomegaly, hypercholesterolemia, elevated transaminase levels and hepatic steatosis in addition to attenuation of inflammatory markers. Notably, all DIO-NASH mice demonstrated ≥ 2 point significant improvement in NAFLD Activity Score following dietary intervention. While not improving fibrosis stage, chow-reversal reduced quantitative fibrosis markers (PSR, collagen 1a1, α-SMA), concurrent with improved liver mitochondrial respiration, complete reversal of p21 overexpression, lowered γ-H2AX levels and widespread suppression of gene expression markers of hepatocellular senescence. Conclusions: Dietary intervention (chow reversal) substantially improves metabolic, biochemical and histological hallmarks of NASH and fibrosis in GAN DIO-NASH mice. These benefits were reflected by progressive clearance of senescent hepatocellular cells, making the model suitable for profiling potential senotherapeutics in preclinical drug discovery for NASH.

AB - Background: Hepatocellular senescence may be a causal factor in the development and progression of non-alcoholic steatohepatitis (NASH). The most effective currently available treatment for NASH is lifestyle intervention, including dietary modification. This study aimed to evaluate the effects of dietary intervention on hallmarks of NASH and molecular signatures of hepatocellular senescence in the Gubra-Amylin NASH (GAN) diet-induced obese (DIO) and biopsy-confirmed mouse model of NASH. Methods: GAN DIO-NASH mice with liver biopsy-confirmed NASH and fibrosis received dietary intervention by switching to chow feeding (chow reversal) for 8, 16 or 24 weeks. Untreated GAN DIO-NASH mice and chow-fed C57BL/6J mice served as controls. Pre-to-post liver biopsy histology was performed for within-subject evaluation of NAFLD Activity Score and fibrosis stage. Terminal endpoints included blood/liver biochemistry, quantitative liver histology, mitochondrial respiration and RNA sequencing. Results: Chow-reversal promoted substantial benefits on metabolic outcomes and liver histology, as demonstrated by robust weight loss, complete resolution of hepatomegaly, hypercholesterolemia, elevated transaminase levels and hepatic steatosis in addition to attenuation of inflammatory markers. Notably, all DIO-NASH mice demonstrated ≥ 2 point significant improvement in NAFLD Activity Score following dietary intervention. While not improving fibrosis stage, chow-reversal reduced quantitative fibrosis markers (PSR, collagen 1a1, α-SMA), concurrent with improved liver mitochondrial respiration, complete reversal of p21 overexpression, lowered γ-H2AX levels and widespread suppression of gene expression markers of hepatocellular senescence. Conclusions: Dietary intervention (chow reversal) substantially improves metabolic, biochemical and histological hallmarks of NASH and fibrosis in GAN DIO-NASH mice. These benefits were reflected by progressive clearance of senescent hepatocellular cells, making the model suitable for profiling potential senotherapeutics in preclinical drug discovery for NASH.

KW - Animal model

KW - Dietary intervention

KW - Fibrosis

KW - Hepatocellular senescence

KW - Mitochondrial respiration

KW - Non-alcoholic steatohepatitis

U2 - 10.1186/s12876-024-03141-x

DO - 10.1186/s12876-024-03141-x

M3 - Journal article

C2 - 38308212

AN - SCOPUS:85183732059

VL - 24

JO - B M C Gastroenterology

JF - B M C Gastroenterology

SN - 1471-230X

IS - 1

M1 - 59

ER -

ID: 385137097